DRUG · Unmapped registry intervention
Intravenous nicardipine hydrochloride
Find medicine records ·
Find other trials using this name
Clinical trial
Antihypertensive Treatment of Acute Cerebral Hemorrhage-II
NCT01176565
Drugs and interventions used in this trial
1 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
No matching interventions in this trial.
Study at a glance
Registry-backedAntihypertensive Treatment of Acute Cerebral Hemorrhage-II
Design: INTERVENTIONAL · Status: TERMINATED · Phase: PHASE3
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Interventions
Sponsors & collaborators
University of Minnesotalead sponsor
Medical University of South Carolinacollaborator
Johns Hopkins Universitycollaborator
University of Michigancollaborator
Neurocritical Care Research Networkcollaborator
Japan Cardiovascular Research Foundationcollaborator
Beijing Tiantan Hospitalcollaborator
China Medical University Hospitalcollaborator
University Hospital Heidelbergcollaborator
Seoul National University Hospitalcollaborator
Mapped research locations
HoustonTexas, United States4PhiladelphiaPennsylvania, United States4TaipeiTaiwan4TokyoJapan4New YorkNew York, United States3BostonMassachusetts, United States3AtlantaGeorgia, United States3SeoulSouth Korea3DetroitMichigan, United States3AustinTexas, United States3New OrleansLouisiana, United States3PittsburghPennsylvania, United States2
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT01176565 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.